Cramer's lightning round: Hims & Hers Health is not a buy
- It's that time again! "Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.
Hims & Hers Health Inc: "Hims & Hers lose money ... I'm not recommending stocks that are losing a lot of money."
Two Harbors Investment Corp: "I'm not going there. We've seen a lot of companies like that. ... I'm not playing."
Shell Midstream Partners LP: "[Enterprise Product Partners], that's the best one if you want to be in that group now."
Healthcare Realty Trust Inc: "I thought [the company's merger with Healthcare Trust of America] made a lot of sense. ... I like it."
DraftKings Inc: "[Kynikos Associates founder] Jim Chanos says it's a great short. I think the time to short the stock was much, much higher."
Gilead Sciences Inc: "I know it looks very, very cheap. But you know what, that's not why we buy drugs stocks. We buy drug stocks because they've got growth, and Gilead has none."
Sign up now for the CNBC Investing Club to follow Jim Cramer's every move in the market.
Questions for Cramer?
Call Cramer: 1-800-743-CNBC
Want to take a deep dive into Cramer's world? Hit him up!
Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram
Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com